Inflammatory cytokines and atrial fibrillation: current and prospective views

References

• FusterVRydenLEAsingerRWAmerican College of Cardiology (ACC)/American Heart Association (AHA)/European Society of Cardiology (ESC) guidelines for the management of patients with atrial fibrillation: executive summary report of the ACC/AHA Task Force on practice guidelines and the ESC Committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and ElectrophysiologyCirculation200110421182150
   PubMed Web of Science ®Google Scholar
• GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) studyJAMA20012852370237511343485
   PubMed Web of Science ®Google Scholar
• BenjaminEJWolfPAD’AgostinoRBImpact of atrial fibrillation on the risk of death: the Framingham Heart StudyCirculation1998989469529737513
   PubMed Web of Science ®Google Scholar
• GronefeldGCLilienthalJKuckKHPharmacological Intervention in Atrial Fibrillation (PIAF) Study InvestigatorsImpact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation: results from a prospective randomized studyEur Heart J2003241430143612909072
   PubMed Web of Science ®Google Scholar
• SaxenaRLewisSBergeERisk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke TrialStroke2001322333233711588322
   PubMed Web of Science ®Google Scholar
• SpachMSDolberPCRelating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle: evidence for electrical uncoupling of side-to-side fiber connections with increasing ageCardiovasc Res198658356371
   Google Scholar
• FujikiASakamotoTNishidaKRelation of Interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillationJ Cardiovasc Pharmacol200750326426617878753
   PubMed Web of Science ®Google Scholar
• UcarHITokMAtalarEPredictive significance of plasma levels of Interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgeryHeart Surg Forum2007102E13113517597037
   PubMed Web of Science ®Google Scholar
• WuZKLaurikkaJVikmanSHigh postoperative Interleukin-8 levels related to atrial fibrillation in patients undergoing coronary artery bypass surgeryWorld J Surg2008322643264918850246
   PubMed Web of Science ®Google Scholar
• SjoholmANystromTEndothelial inflammation in insulin resistanceLancet200536561061215708106
   PubMed Web of Science ®Google Scholar
• NadarSBlannADLipGYEndothelial dysfunction: methods of assessment and application to hypertensionCurr Pharm Des2004103591360515579056
   PubMed Web of Science ®Google Scholar
• BoosCJLipGYHThe role of inflammation in atrial fibrillationInt J Clin Pract20055987087216033603
   PubMed Web of Science ®Google Scholar
• BruinsPte VelthuisHYazdanbakhshAPActivation of the complement system during and after cardiopulmonary bypass surgery: post surgery activation involves C-reactive protein and is associated with postoperative arrhythmiaCirculation199796354235489396453
   PubMed Web of Science ®Google Scholar
• AndersonJLAllen MaycockCAFrequency of elevation of C-reactive protein in atrial fibrillationAm J Cardiol2004941255125915541240
   PubMed Web of Science ®Google Scholar
• YaredJPStarrNJTorresFKEffects of single dose, post induction dexamethasone on recovery after cardiac surgeryAnn Thorac Surg2000691420142410881816
   PubMed Web of Science ®Google Scholar
• SchottenUAusmaJStellbrinkCCellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillationCirculation200110369169811156881
   PubMed Web of Science ®Google Scholar
• KuceraJPRudyYMechanistic insights into very slow conduction in branching cardiac tissue: a model studyCirc Res20018979980611679410
   PubMed Web of Science ®Google Scholar
• KostinSKleinGSzalayZStructural correlate of atrial fibrillation in human patientsCardiovasc Res20025436137912062341
   PubMed Web of Science ®Google Scholar
• BoldtAWetzelULauschkeJFibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve diseaseHeart20049040040515020515
   PubMed Web of Science ®Google Scholar
• HadiHAMahmeedWASuwaidiJAPleiotropic effects of statins in atrial fibrillation patients: the evidenceVasc Health Risk Manag20095353355119590588
   PubMedGoogle Scholar
• FrustaciAChimentiCBellocciFHistological substrate of atrial biopsies in patients with lone atrial fibrillationCirculation199796118011849286947
   PubMed Web of Science ®Google Scholar
• TsaiCTLaiLPKuoKTAngiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodelingCirculation2008b117334435518172037
   PubMed Web of Science ®Google Scholar
• NeumanRBBloomHLShukrullahIOxidative stress markers are associated with persistent atrial fibrillationClin Chem20075391652165717599958
   PubMed Web of Science ®Google Scholar
• TangRBDongJZLiuXPInflammation and atrial fibrillation: is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation?Med Hypotheses200667346246616793213
   PubMed Web of Science ®Google Scholar
• NakamuraYNakamuraKFukushima-KusanoKTissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesisThromb Res2003111313714214678810
   PubMed Web of Science ®Google Scholar
• AnnéWWillemsRRoskamsTMatrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillationCardiovasc Res200567465566615913581
   PubMed Web of Science ®Google Scholar
• BoosCJLipGYJilmaBEndotoxemia, inflammation, and atrial fibrillationAm J Cardiol2007100698698817826383
   PubMed Web of Science ®Google Scholar
• GuazziMBellettiSBiancoEEndothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversionAm J Physiol2006291H921928
   PubMed Web of Science ®Google Scholar
• KimYMGuzikTJZhangYHA myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillationCirc Res20059762963616123335
   PubMed Web of Science ®Google Scholar
• ChoudharyGDudleySCJrHeart failure, oxidative stress, and ion channel modulationCongest Heart Fail2002814815512045383
   PubMedGoogle Scholar
• TouyzRMSchiffrinELReactive oxygen species in vascular biology: implications in hypertensionHistochem Cell Biol200412233935215338229
   PubMed Web of Science ®Google Scholar
• AdamsJDJrLauterburgBHMitchellJRPlasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stressJ Pharmacol Exp Ther19832277497546655568
   PubMed Web of Science ®Google Scholar
• SekoYSekoYTakahashiNPulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytesBiochem Biophys Res Commun19992544624659918861
   PubMed Web of Science ®Google Scholar
• SekoYSekoYTakahashiNPulsatile stretch activates mitogen activated protein kinase (MAPK) family members and focal adhesion kinase (p125FAK) in cultured rat cardiac myocytesBiochem Biophys Res Commun199925981410334907
   PubMed Web of Science ®Google Scholar
• LeeSHChenYCChenYJTumor necrosis factor-α alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytesLife Sci200780191806181517383682
   PubMed Web of Science ®Google Scholar
• SekoYImaiYSuzukiSSerum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapyClin Sci1997924534549176017
   PubMed Web of Science ®Google Scholar
• BlannADChoudhuryAFreestoneBSoluble CD40 ligand and atrial fibrillation: Relationship to platelet activation, and endothelial damage/dysfunctionInt J Cardiol2008127113513717555832
   PubMed Web of Science ®Google Scholar
• ChoudhuryAChungIPanjaNSoluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillationChest200813457458118641098
   PubMed Web of Science ®Google Scholar
• MarcusGMWhooleyMAGliddenDVInterleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul StudyAm Heart J2008155230330918215601
   PubMed Web of Science ®Google Scholar
• DudleySCJrHochNEMcCannLAAtrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidasesCirculation20051121266127316129811
   PubMed Web of Science ®Google Scholar
• SataNHamadaNHorinouchiTC-reactive protein and atrial fibrillation: is inflammation a consequence or a cause of atrial fibrillationJpn Heart J20044544144515240964
   PubMedGoogle Scholar
• LamiraultGGaboritNLe MeurNGene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in manJ Mol Cell Cardiol200640117318416242148
   PubMed Web of Science ®Google Scholar
• SpodickDHArrhythmias during acute pericarditis: a prospective study of 100 consecutive casesJAMA19762353941945999
   PubMed Web of Science ®Google Scholar
• MorgeraTDi LenardaADreasLElectrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changesAm Heart J19921244554671636589
   PubMed Web of Science ®Google Scholar
• MaixentJMPaganelliFScaglioneJAntibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillationJ Cardiovasc Electrophysiol199896126179654226
   PubMed Web of Science ®Google Scholar
• CarnesCAChungMKNakayamaTAscorbate attenuates atrial pacing–induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillationCirc Res.200189e32e3811557745
   PubMed Web of Science ®Google Scholar
• AvilesRJMartinDOApperson-HansenCInflammation as a risk factor for atrial fibrillationCirculation20031083006301014623805
   PubMed Web of Science ®Google Scholar
• ChungMKMartinDOSprecherDC-Reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillationCirculation20011042886289111739301
   PubMed Web of Science ®Google Scholar
• Shiroshita-TakeshitaASchramGLavoieJEffect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atria tachycardia remodeling in dogsCirculation20041102313231915477401
   PubMed Web of Science ®Google Scholar
• KorantzopoulosPKolettisTMKountourisEOral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammationInt J Cardiol2005a10232132615982504
   PubMed Web of Science ®Google Scholar
• KorantzopoulosPKolettisTMKountourisEVariation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation: is there an association with early recurrence ratesInt J Clin Pract2005b5988188516033606
   PubMed Web of Science ®Google Scholar
• KaplanMHVolanakisJEInteraction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelinJ Immunol1974112213521474151108
   PubMed Web of Science ®Google Scholar
• VolanakisJEWirtzKWInteraction of C-reactive protein with artificial phosphatidylcholine bi-layersNature1979281155157471064
   PubMed Web of Science ®Google Scholar
• BlakeGJRidkerPMC-reactive protein and other inflammatory risk markers in acute coronary syndromesJ Am Coll Cardiol.200341Suppl 437S42S12644339
   PubMed Web of Science ®Google Scholar
• ConwayDSBugginsPHughesEPredictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillationAm J Cardiol2004a4508510
   Web of Science ®Google Scholar
• ConwayDSBugginsPHughesERelationship of Interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillationJ Am Coll Cardiol2004b432075208215172416
   PubMed Web of Science ®Google Scholar
• SataNHamadaNHorinouchiTC-reactive protein and atrial fibrillation: is inflammation a consequence fibrillationJpn Heart J20044544144515240964
   PubMedGoogle Scholar
• PsychariSNApostolouTSSinosLRelation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillationAm J Cardiol20059576476715757607
   PubMed Web of Science ®Google Scholar
• AsselbergsFWvan den BergMPDiercksGFC-reactive protein and micro-albuminuria are associated with atrial fibrillationInt J Cardiol200598737715676170
   PubMed Web of Science ®Google Scholar
• WatanabeTTakeishiYHironoOC-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillationHeart Vessels200520454915772777
   PubMed Web of Science ®Google Scholar
• DernellisJPanaretouMRelationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillationEur Heart J2004251100110715231367
   PubMed Web of Science ®Google Scholar
• OralHKnightBPOzaydinMClinical significance of early recurrences of atrial fibrillation after pulmonary vein isolationJ Am Coll Cardiol20024010010412103262
   PubMed Web of Science ®Google Scholar
• DernellisJPanaretouMEffect of C-reactive protein reduction on paroxysmal atrial fibrillationAm Heart J200550106416290998
   PubMedGoogle Scholar
• VerheuleSSatoTEverettT4thIncreased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by over expression of TGF-β1Circ Res2004941458146515117823
   PubMed Web of Science ®Google Scholar
• WuWKeDXuCXCollagen type I and Interleukin-1 beta gene expression in human atria during atrial fibrillationZhonghua Nei Ke Za Zhi2006451080781017217743
   PubMedGoogle Scholar
• RizosITsiodrasSRigopoulosAGInterleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcomeCytokine200740315716417923414
   PubMed Web of Science ®Google Scholar
• TveitASeljeflotIGrundvoldIEffect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillationAm J Cardiol200799111544154817531578
   PubMed Web of Science ®Google Scholar
• KatohHShimadaTInoueSReduced high serum hepatocyte growth factor levels after successful cardioversion in patients with atrial fibrillationClin Exp Pharmacol Physiol200431314515115008956
   PubMed Web of Science ®Google Scholar
• AtalarEHaznedarogluICAcilTOzerPatients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmiaPlatelets2003147–840741114713509
   PubMed Web of Science ®Google Scholar
• KamathSChinBSBlannADA study of platelet activation in paroxysmal, persistent and permanent atrial fibrillationBlood Coagul Fibrinolysis200213762763612439149
   PubMed Web of Science ®Google Scholar
• GoetteAJentsch-UllrichKLendeckelUEffect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide?Circulation2003108202446244914610014
   PubMed Web of Science ®Google Scholar
• LiubaIAhlmrothHJonassonLWalfridssonHSource of inflammatory markers in patients with atrial fibrillationEuropace200810784885318523031
   PubMed Web of Science ®Google Scholar
• SteinAWesslingGDeisenhoferISystemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilizationEuropace200810444444918339614
   PubMed Web of Science ®Google Scholar
• MarcusGMSmithLMGliddenDVMarkers of inflammation before and after curative ablation of atrial flutterHeart Rhythm20085221522118242542
   PubMed Web of Science ®Google Scholar
• PolyakovaVMiyagawaSSzalayZAtrial extracellular matrix remodeling in patients with atrial fibrillationJ Cell Mol Med200812118920818194448
   PubMed Web of Science ®Google Scholar
• GoetteAArndtMRöckenCCalpains and cytokines in fibrillating human atriaAm J Physiol Heart Circ Physiol20022831H26427212063299
   PubMed Web of Science ®Google Scholar
• GaudinoMAndreottiFZamparelliRThe −174G/C Interleukin-6 polymorphism influences postoperative Interleukin-6 Levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?Circulation2003108suppl IIII19519912970232
   PubMed Web of Science ®Google Scholar
• RoldánVMarínFMartínezJGRelation of Interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillationAm J Cardiol200595788188215781023
   PubMed Web of Science ®Google Scholar
• ConwayDSBugginsPHughesEPrognostic significance of raised plasma levels of Interleukin-6 and C-reactive protein in atrial fibrillationAm Heart J2004148346246615389233
   PubMed Web of Science ®Google Scholar
• LipGYPatelJVHughesEHigh-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillationStroke20073841229123717332453
   PubMed Web of Science ®Google Scholar
• FerroDLoffredoLPolimeniLSoluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillationArterioscler Thromb Vasc Biol200727122763276817901373
   PubMed Web of Science ®Google Scholar
• Li-Saw-HeeFLBlannADGurneyDPlasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation: effects of cardioversion and return of left atrial functionEur Heart J2001221741174711511124
   PubMed Web of Science ®Google Scholar
• MarinFRoldanVClimentVEPlasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillationHeart2004901162116615367514
   PubMed Web of Science ®Google Scholar
• YamauchiKFuruiHTaniguchiNPlasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillationJpn Heart J19862744814872946878
   PubMedGoogle Scholar
• ConwayDSBugginsPHughesERelation of Interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillationAm J Cardiol2004931113681373A615165916
   PubMed Web of Science ®Google Scholar
• ThambidoraiSKParakhKMartinDORelation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillationAm J Cardiol20049480580715374796
   PubMed Web of Science ®Google Scholar
• FeinbergWMPearceLAHartRGMarkers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III studyStroke1999302547255310582976
   PubMed Web of Science ®Google Scholar
• HammwöhnerMIttensonADierkesJPlatelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillationExp Biol Med (Maywood)2007232458158917392495
   PubMed Web of Science ®Google Scholar
• FukuchiMWatanabeJKumagaiKIncreased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendageJ Am Coll Cardiol2001371436144211300458
   PubMed Web of Science ®Google Scholar
• ChoudhuryAFreestoneBPatelJRelationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillationChest20071213261913191918079224
   PubMed Web of Science ®Google Scholar
• ChungNABelgoreFLi-Saw-HeeFLIs the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factorStroke2002332187219112215585
   PubMed Web of Science ®Google Scholar
• MarínFCorralJRoldánVFactor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillationJ Mol Cell Cardiol2004937369970415350843
   PubMed Web of Science ®Google Scholar
• HerskowitzAMayneAEWilloughbySBPatterns of myocardial cell adhesion molecule expression in human endomyocardial biopsies after cardiac transplantation. Induced ICAM-1 and VCAM-1 related to implantation and rejectionAm J Pathol1994145108210947977640
   PubMed Web of Science ®Google Scholar
• QiaoJHRuanXMTrentoAExpression of cell adhesion molecules in human cardiac allograft rejectionJ Heart Lung Transplant1992119209251384703
   PubMed Web of Science ®Google Scholar
• TaylorPMRoseMLYacoubMHInduction of vascular adhesion molecules during rejection of human cardiac allograftsTransplantation1992544514571384180
   PubMed Web of Science ®Google Scholar
• KamathSBlannADCaineGJPlatelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillationStroke20025335:1237124211988597
   PubMed Web of Science ®Google Scholar
• SemenovAVRomanovYALoktionovaSAProduction of soluble P-selectin by platelets and endothelial cellsBiochemistry (Mosc)1999641326133510611541
   PubMed Web of Science ®Google Scholar
• LiNWallenNHHjemdahlPEvidence for prothrombotic effects of exercise and limited protection by aspirinCirculation19991001374137910500036
   PubMed Web of Science ®Google Scholar
• ConnorCMGurbelPASerebruanyVLUsefulness of soluble and surface bound P-selectin in detecting platelet activity in patients with congestive heart failureAm J Cardiol1999831345134910235093
   PubMed Web of Science ®Google Scholar
• JilmaBBlannAPernerstorferTRegulation of adhesion molecules during human endotoxemia: no acute effects of aspirinAm J Respir Crit Care Med199915985786310051263
   PubMed Web of Science ®Google Scholar
• RoldánVMarínFBlannADInterleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillationEur Heart J200324141373138012871695
   PubMed Web of Science ®Google Scholar
• ShimanoMTsujiYIndenYPioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failureHeart Rhythm20085345145918313605
   PubMed Web of Science ®Google Scholar
• ChelloMSpadaccioCPattiGSimvastatin reduces platelet–endocardium adhesion in atrial fibrillationAtherosclerosis200841972:58859517904146
   PubMed Web of Science ®Google Scholar
• LeeKWEverettTH4thRahmutulaDPirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failureCirculation2006114161703171217030685
   PubMed Web of Science ®Google Scholar
• SawayaSERajawatYSRamiTGDown regulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factorAm J Physiol Heart Circ Physiol20072923H1561156717122196
   PubMed Web of Science ®Google Scholar
• GunaydinSAyranciogluKDikmenEClinical effects of leukofiltration and surface modification on post-cardiopulmonaryPerfusion20072227928818181517
   PubMed Web of Science ®Google Scholar
• AmarDZhangHHeerdtPMStatin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive proteinChest200512853421342716304294
   PubMed Web of Science ®Google Scholar
• YaredJPBakriMHErzurumSCEffect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trialJ Cardiothorac Vasc Anesth2007211687517289483
   PubMed Web of Science ®Google Scholar
• ChenXBingZHeJDownregulation of peroxisome proliferator-activated receptor-gamma expression in hypertensive atrial fibrillationClin Cardiol200932633734519569080
   PubMed Web of Science ®Google Scholar
• MarcusGMWhooleyMAGliddenDVInterleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul StudyAm Heart J2008155230330918215601
   PubMed Web of Science ®Google Scholar
• DuyguHBarisikVKurtHPrognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillationEuropace20081021021418184662
   PubMed Web of Science ®Google Scholar
• ShanHZhangYLuYDownregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in caninesCardiovasc Res200983346547219398468
   PubMed Web of Science ®Google Scholar
• ChenCLHuangSKLinJLUpregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillationJ Mol Cell Cardiol200845674275318692064
   PubMed Web of Science ®Google Scholar
• SabaSJanczewskiAMBakerLCAtrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific over expression of tumor necrosis factor-αAm J Physiol Heart Circ Physiol2005289H1456146715923312
   PubMed Web of Science ®Google Scholar
• XuJRenJFMugelliAAge-dependent atrial remodeling induced by recombinant human Interleukin-11: implications for atrial flutter/fibrillationJ Cardiovasc Pharmacol200239343544011862123
   PubMed Web of Science ®Google Scholar
• GedikliODoganAAltuntasIInflammatory markers according to types of atrial fibrillationInt J Cardiol2007120219319717240468
   PubMed Web of Science ®Google Scholar